The rapid development and high efficacy of mRNA vaccines, such as those developed for COVID-19, have demonstrated several benefits: - Speed: mRNA vaccines can be designed and manufactured quickly. - Efficacy: Clinical trials have shown high efficacy rates in preventing disease. - Safety: mRNA vaccines do not use live virus, reducing the risk of vaccine-induced infection. - Adaptability: They can be updated relatively easily to combat new variants.
